Viewing Study NCT04636333


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2025-12-26 @ 1:32 AM
Study NCT ID: NCT04636333
Status: UNKNOWN
Last Update Posted: 2022-03-31
First Post: 2020-11-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)
Sponsor: Jiangsu Province Centers for Disease Control and Prevention
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module